Tenax Therapeutics (TENX) Change in Intangibles (2010 - 2015)
Tenax Therapeutics recorded quarterly Change in Intangibles of $4961.0 in Q2 2015, down 67.13% quarter-over-quarter from $15095.0 in Q3 2014.
Tenax Therapeutics' Change in Intangibles history runs 6 years deep, the most recent figure standing at $4961.0 for Q2 2015.
- In Q2 2015, Change in Intangibles changed N/A year-over-year to $4961.0; the TTM figure through Mar 2016 stood at $4961.0 (changed N/A YoY), while the FY2015 annual figure was $105423.0, down 23.18% from the prior year.
- Change in Intangibles came in at $4961.0 for Q2 2015 at Tenax Therapeutics, down from $15095.0 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $301622.0 in Q1 2011 to a low of $4961.0 in Q2 2015.
- A 5-year average of $55093.6 and a median of $36182.0 in 2012 frame the typical range for Change in Intangibles.
- Across the five-year window, Change in Intangibles surged 236.52% in 2011 and tumbled 85.67% in 2012, its largest moves.
- Tenax Therapeutics' Change in Intangibles stood at $65922.0 in 2011, then tumbled by 44.4% to $36653.0 in 2012, then dropped by 2.57% to $35711.0 in 2013, then plunged by 57.73% to $15095.0 in 2014, then tumbled by 67.13% to $4961.0 in 2015.
- According to Business Quant data, Change in Intangibles over the past three periods registered $4961.0, $15095.0, and $33994.0 for Q2 2015, Q3 2014, and Q2 2014 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,980.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 4,961.00 |
| Jun 30, 2015 | 4,961.00 |
| Jul 31, 2014 | 15,095.00 |
| Jul 31, 2014 | 15,095.00 |
| Apr 30, 2014 | 33,994.00 |
| Apr 30, 2014 | 33,994.00 |
| Jan 31, 2014 | 34,373.00 |
| Jan 31, 2014 | 34,373.00 |
| Oct 31, 2013 | 35,711.00 |
| Oct 31, 2013 | 35,711.00 |
| Jul 31, 2013 | 33,156.00 |
| Jul 31, 2013 | 33,156.00 |
| Apr 30, 2013 | 43,849.00 |
| Apr 30, 2013 | 43,849.00 |
| Jan 31, 2013 | 32,941.00 |
| Jan 31, 2013 | 32,941.00 |
| Oct 31, 2012 | 36,653.00 |
| Oct 31, 2012 | 36,653.00 |
| Jul 31, 2012 | 21,409.00 |
| Jul 31, 2012 | 21,409.00 |
| Apr 30, 2012 | 51,908.00 |
| Apr 30, 2012 | 51,908.00 |
| Jan 31, 2012 | 43,223.00 |
| Jan 31, 2012 | 43,223.00 |
| Oct 31, 2011 | 65,922.00 |
| Oct 31, 2011 | 65,922.00 |
| Jul 31, 2011 | 86,684.00 |
| Jul 31, 2011 | 86,684.00 |
| Apr 30, 2011 | 39,997.00 |
| Apr 30, 2011 | 39,997.00 |
| Jan 31, 2011 | 301,622.00 |
| Jan 31, 2011 | 301,622.00 |
| Oct 31, 2010 | -48,289.00 |
| Oct 31, 2010 | -48,289.00 |
| Jul 31, 2010 | -70,215.00 |
| Jul 31, 2010 | -70,215.00 |